Search

Your search keyword '"Respirovirus Infections metabolism"' showing total 115 results

Search Constraints

Start Over You searched for: Descriptor "Respirovirus Infections metabolism" Remove constraint Descriptor: "Respirovirus Infections metabolism"
115 results on '"Respirovirus Infections metabolism"'

Search Results

1. Critical role of G3BP1 in bovine parainfluenza virus type 3 (BPIV3)-inhibition of stress granules formation and viral replication.

2. ADAR1 Biology Can Hinder Effective Antiviral RNA Interference.

3. Keap1 moderates the transcription of virus induced genes through G9a-GLP and NFκB p50 recruitment.

4. Might Routine Vitamin A Monitoring in Cystic Fibrosis Patients Reduce Virus-Mediated Lung Pathology?

5. Human parainfluenza virus type 1 regulates cholesterol biosynthesis and establishes quiescent infection in human airway cells.

6. Curcumin Inhibits Replication of Human Parainfluenza Virus Type 3 by Affecting Viral Inclusion Body Formation.

7. Arginine monomethylation by PRMT7 controls MAVS-mediated antiviral innate immunity.

8. Neutrophils in respiratory viral infections.

9. The Kv1.3 ion channel acts as a host factor restricting viral entry.

10. Leveraging 3D Model Systems to Understand Viral Interactions with the Respiratory Mucosa.

11. T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1.

12. Bta-miR-98 Suppresses Replication of Caprine Parainfluenza Virus Type 3 Through Inhibiting Apoptosis by Targeting Caspase-3.

13. Quantitative single-cell interactomes in normal and virus-infected mouse lungs.

14. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection.

15. The RNA binding protein Quaking represses host interferon response by downregulating MAVS.

16. The microRNAs miR-302b and miR-372 regulate mitochondrial metabolism via the SLC25A12 transporter, which controls MAVS-mediated antiviral innate immunity.

17. Mice deficient in NKLAM have attenuated inflammatory cytokine production in a Sendai virus pneumonia model.

18. Proteomics analysis reveals heat shock proteins involved in caprine parainfluenza virus type 3 infection.

19. Virion-Associated Cholesterol Regulates the Infection of Human Parainfluenza Virus Type 3.

20. Identification of key genes and signaling pathways during Sendai virus infection in vitro.

21. USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling.

22. Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly.

23. Sec13 is a positive regulator of VISA-mediated antiviral signaling.

24. Analysis of microRNAs Expression Profiles in Madin-Darby Bovine Kidney Cells Infected With Caprine Parainfluenza Virus Type 3.

25. Pathogen Recognition by CD4 Effectors Drives Key Effector and Most Memory Cell Generation Against Respiratory Virus.

26. Inclusion bodies of human parainfluenza virus type 3 inhibit antiviral stress granule formation by shielding viral RNAs.

27. Virus Infection Triggers MAVS Polymers of Distinct Molecular Weight.

28. Quantitative Proteomics Identified TTC4 as a TBK1 Interactor and a Positive Regulator of SeV-Induced Innate Immunity.

29. Verification of genetic loci responsible for the resistance/susceptibility to the Sendai virus infection using congenic mice.

30. DUSP1 regulates apoptosis and cell migration, but not the JIP1-protected cytokine response, during Respiratory Syncytial Virus and Sendai Virus infection.

31. The RNA binding protein La/SS-B promotes RIG-I-mediated type I and type III IFN responses following Sendai viral infection.

32. Replication defective viral genomes exploit a cellular pro-survival mechanism to establish paramyxovirus persistence.

33. The dynamic interacting landscape of MAPL reveals essential functions for SUMOylation in innate immunity.

34. Global quantitative proteomic analysis profiles host protein expression in response to Sendai virus infection.

35. Inclusion Body Fusion of Human Parainfluenza Virus Type 3 Regulated by Acetylated α-Tubulin Enhances Viral Replication.

36. Study on JNK/AP-1 signaling pathway of airway mucus hypersecretion of severe pneumonia under RSV infection.

37. Phosphoproteome characterization reveals that Sendai virus infection activates mTOR signaling in human epithelial cells.

38. FcγRIIB prevents inflammatory type I IFN production from plasmacytoid dendritic cells during a viral memory response.

39. Engagement of Fas on Macrophages Modulates Poly I:C induced cytokine production with specific enhancement of IP-10.

40. Structure-function analysis of CCL28 in the development of post-viral asthma.

41. Comparison of temporal transcriptomic profiles from immature lungs of two rat strains reveals a viral response signature associated with chronic lung dysfunction.

42. Terminal sialic acid linkages determine different cell infectivities of human parainfluenza virus type 1 and type 3.

43. Phosphoprotein of human parainfluenza virus type 3 blocks autophagosome-lysosome fusion to increase virus production.

44. MAVS-MKK7-JNK2 defines a novel apoptotic signaling pathway during viral infection.

45. An amino acid of human parainfluenza virus type 3 nucleoprotein is critical for template function and cytoplasmic inclusion body formation.

46. Human kinome analysis reveals novel kinases contributing to virus infection and retinoic-acid inducible gene I-induced type I and type III IFN gene expression.

47. [Study on functions of N-carbohydrate chains in human parainfluenza virus type 3 hemagglutinin-neuraminidase protein].

48. DEAF1 is a Pellino1-interacting protein required for interferon production by Sendai virus and double-stranded RNA.

49. Antagonism to human BST-2/tetherin by Sendai virus glycoproteins.

50. Stabilization of human interferon-α1 mRNA by its antisense RNA.

Catalog

Books, media, physical & digital resources